Blood Neurofilament Light in Remote Settings: Alternative Protocols to Support Sample Collection in Challenging Pre-analytical Conditions

Overview

Journal Alzheimers Dement (Amst)

Date 2021 Mar 5

PMID 33665338

Citations 14

Authors

Joel Simren

Nicholas J Ashton

Kaj Blennow

Henrik Zetterberg

Affiliations

Soon will be listed here.

Abstract

Introduction: This study investigated alternative pre-analytical handling of blood for neurofilament light (NfL) analysis where resources are limited.

Method: Plasma NfL was measured with single molecule array after alternative blood processing procedures: dried plasma spots (DPS), dried blood spots (DBS), and delayed 48-hour centrifugation. These were compared to standardized plasma processing (reference standard [RS]). In a discovery cohort (n = 10) and a confirmatory cohort (n = 21), whole blood was obtained from individuals with unknown clinical etiology. In the confirmatory cohort, delayed centrifugation protocol was paired with either 37°C incubation or sample shaking to test the effect of these parameters.

Results: Delayed centrifugation (R = 0.991) and DPS (discovery cohort, R= 0.954; confirmatory cohort, DPS: R = 0.961) methods were strongly associated with the RS. Delayed centrifugation with higher temperatures (R = 0.995) and shaking (R = 0.975) did not affect this association. DPS (< 0.001) returned concentrations considerably lower than the RS.

Discussion: DPS or delayed centrifugation are viable pre-analytical procedures for the accurate quantification of plasma NfL.

Citing Articles

Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials.

Weiner M, Kanoria S, Miller M, Aisen P, Beckett L, Conti C Alzheimers Dement. 2024; 21(1):e14321.

PMID: 39711072 PMC: 11775462. DOI: 10.1002/alz.14321.

Quantification of neurofilament light and glial fibrillary acidic protein in finger-prick blood.

Kolanko M, Huber H, David M, Montoliu-Gaya L, Simren J, Blennow K Brain Commun. 2024; 6(3):fcae151.

PMID: 38903933 PMC: 11189302. DOI: 10.1093/braincomms/fcae151.

Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting.

Zeng X, Chen Y, Sehrawat A, Lee J, Lafferty T, Kofler J Mol Neurodegener. 2024; 19(1):40.

PMID: 38750570 PMC: 11095038. DOI: 10.1186/s13024-024-00711-1.

The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact.

Kalaria R, Maestre G, Mahinrad S, Acosta D, Akinyemi R, Alladi S Alzheimers Dement. 2024; 20(6):4290-4314.

PMID: 38696263 PMC: 11180946. DOI: 10.1002/alz.13836.

Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.

Huber H, Blennow K, Zetterberg H, Boada M, Jeromin A, Weninger H Alzheimers Dement. 2024; 20(4):2340-2352.

PMID: 38284555 PMC: 11032540. DOI: 10.1002/alz.13697.

References

Verberk I, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A . Combination of plasma amyloid beta and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther. 2020; 12(1):118. PMC: 7523295. DOI: 10.1186/s13195-020-00682-7. View

Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P . Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease. Alzheimers Res Ther. 2018; 10(1):71. PMC: 6064615. DOI: 10.1186/s13195-018-0404-9. View

Palmqvist S, Janelidze S, Quiroz Y, Zetterberg H, Lopera F, Stomrud E . Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. 2020; 324(8):772-781. PMC: 7388060. DOI: 10.1001/jama.2020.12134. View

Mattsson N, Cullen N, Andreasson U, Zetterberg H, Blennow K . Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 2019; 76(7):791-799. PMC: 6583067. DOI: 10.1001/jamaneurol.2019.0765. View

Rodriguez J, Karikari T, Suarez-Calvet M, Troakes C, King A, Emersic A . Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol. 2020; 140(3):267-278. PMC: 7423866. DOI: 10.1007/s00401-020-02195-x. View

Katsanos A, Makris K, Stefani D, Koniari K, Gialouri E, Lelekis M . Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage. Stroke. 2017; 48(9):2586-2588. DOI: 10.1161/STROKEAHA.117.018409. View

Mastronardi C, Whittle B, Tunningley R, Neeman T, Paz-Filho G . The use of dried blood spot sampling for the measurement of HbA1c: a cross-sectional study. BMC Clin Pathol. 2015; 15:13. PMC: 4495815. DOI: 10.1186/s12907-015-0013-5. View

Keshavan A, Heslegrave A, Zetterberg H, Schott J . Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles. Alzheimers Dement (Amst). 2018; 10:448-451. PMC: 6131984. DOI: 10.1016/j.dadm.2018.06.001. View

Lombardi V, Carassiti D, Giovannoni G, Lu C, Adiutori R, Malaspina A . The potential of neurofilaments analysis using dry-blood and plasma spots. Sci Rep. 2020; 10(1):97. PMC: 6952412. DOI: 10.1038/s41598-019-54310-y. View

10.

Gisslen M, Price R, Andreasson U, Norgren N, Nilsson S, Hagberg L . Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study. EBioMedicine. 2016; 3:135-140. PMC: 4739412. DOI: 10.1016/j.ebiom.2015.11.036. View

11.

Hviid C, Knudsen C, Parkner T . Reference interval and preanalytical properties of serum neurofilament light chain in Scandinavian adults. Scand J Clin Lab Invest. 2020; 80(4):291-295. DOI: 10.1080/00365513.2020.1730434. View

12.

Karikari T, Pascoal T, Ashton N, Janelidze S, Benedet A, Rodriguez J . Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020; 19(5):422-433. DOI: 10.1016/S1474-4422(20)30071-5. View

13.

Simren J, Ashton N, Blennow K, Zetterberg H . Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre-analytical conditions. Alzheimers Dement (Amst). 2021; 13(1):e12145. PMC: 7896630. DOI: 10.1002/dad2.12145. View

14.

Williams T, Zetterberg H, Chataway J . Neurofilaments in progressive multiple sclerosis: a systematic review. J Neurol. 2020; 268(9):3212-3222. PMC: 8357650. DOI: 10.1007/s00415-020-09917-x. View

15.

Gattringer T, Pinter D, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S . Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017; 89(20):2108-2114. PMC: 5711505. DOI: 10.1212/WNL.0000000000004645. View

16.

Andreotti M, Pirillo M, Guidotti G, Ceffa S, Paturzo G, Germano P . Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay. J Clin Virol. 2009; 47(1):4-7. DOI: 10.1016/j.jcv.2009.11.006. View

17.

Moseby-Knappe M, Mattsson N, Nielsen N, Zetterberg H, Blennow K, Dankiewicz J . Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest. JAMA Neurol. 2018; 76(1):64-71. PMC: 6440255. DOI: 10.1001/jamaneurol.2018.3223. View

18.

Wihersaari L, Ashton N, Reinikainen M, Jakkula P, Pettila V, Hastbacka J . Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial. Intensive Care Med. 2020; 47(1):39-48. PMC: 7782453. DOI: 10.1007/s00134-020-06218-9. View

19.

Shahim P, Zetterberg H, Tegner Y, Blennow K . Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology. 2017; 88(19):1788-1794. PMC: 5419986. DOI: 10.1212/WNL.0000000000003912. View

20.

Mattsson-Carlgren N, Janelidze S, Palmqvist S, Cullen N, Svenningsson A, Strandberg O . Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease. Brain. 2020; 143(11):3234-3241. PMC: 7719022. DOI: 10.1093/brain/awaa286. View